title: Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation.
authors.affiliation: Section of Bone Marrow Transplantation, U.T.M.D. Anderson Cancer Center, Houston 77030.
authors.forename: D
authors.initials: D
authors.lastname: Przepiorka
authors.forename: C
authors.initials: C
authors.lastname: Ippoliti
authors.forename: J
authors.initials: J
authors.lastname: Koberda
authors.forename: K W
authors.initials: KW
authors.lastname: Chan
authors.forename: I F
authors.initials: IF
authors.lastname: Khouri
authors.forename: H E
authors.initials: HE
authors.lastname: Fischer
authors.forename: Y O
authors.initials: YO
authors.lastname: Huh
authors.forename: S M
authors.initials: SM
authors.lastname: Escudier
authors.forename: D
authors.initials: D
authors.lastname: Seong
authors.forename: M
authors.initials: M
authors.lastname: Davis
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002648:Child; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology / Q000517:prevention & control*; D006239:Haplotypes; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy
chemical_list: D007376:Interleukin-2